Brief: Atomo Diagnostics Seeks Trading Halt
26/03/2026 01:37
March 26 (Reuters) - Atomo Diagnostics Ltd AT1.AX: TRADING HALT REQUESTED TO UPDATE ON FDA RESPONSE TO FEBRIDX CLIA WAIVER APPLICATION Further company coverage: AT1.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Atomo Diagnostics
See all newsBrief: Atomo Diagnostics Undertakes Capital Raising To Raise Up To A$4.0 Million
Australia's Atomo Diagnostics slumps on discounted capital raising
Brief: Atomo Diagnostics Seeks Trading Halt
Brief: Atomo Diagnostics Secures Exclusive Licence For Novel Liver Function Test On Pascal
Australia's Atomo Diagnostics jumps on new liver test license